WO1999050295A3 - Agouti-related protein analogs and methods of use - Google Patents
Agouti-related protein analogs and methods of use Download PDFInfo
- Publication number
- WO1999050295A3 WO1999050295A3 PCT/US1999/006968 US9906968W WO9950295A3 WO 1999050295 A3 WO1999050295 A3 WO 1999050295A3 US 9906968 W US9906968 W US 9906968W WO 9950295 A3 WO9950295 A3 WO 9950295A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agouti
- methods
- related protein
- agrp
- analogues
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU39644/99A AU3964499A (en) | 1998-03-30 | 1999-03-30 | Agouti-related protein analogs and methods of use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7995798P | 1998-03-30 | 1998-03-30 | |
US60/079,957 | 1998-03-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999050295A2 WO1999050295A2 (en) | 1999-10-07 |
WO1999050295A3 true WO1999050295A3 (en) | 1999-11-18 |
Family
ID=22153903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/006968 WO1999050295A2 (en) | 1998-03-30 | 1999-03-30 | Agouti-related protein analogs and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3964499A (en) |
WO (1) | WO1999050295A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030808A1 (en) * | 1999-10-27 | 2001-05-03 | The Regents Of The University Of California | Methods and compounds for modulating melanocortin receptor-ligand binding |
EP1125579A3 (en) | 2000-01-18 | 2003-01-02 | Pfizer Products Inc. | Uses of agrp-melanocortin receptor binding modulating compounds |
WO2001085930A2 (en) * | 2000-05-09 | 2001-11-15 | The Regents Of The University Of California | Methods and compounds for modulating melanocortin receptor ligand binding and activity |
EP1483580A4 (en) * | 2002-03-05 | 2006-10-11 | Merck & Co Inc | Biomarker for efficacy of appetite suppressant drugs |
MXPA06012130A (en) | 2004-04-20 | 2007-01-31 | Transtech Pharma Inc | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators. |
US20110160128A1 (en) * | 2008-03-28 | 2011-06-30 | Qingyu Wu | Corin for Treating Obesity and Diabetes |
EP2320738A4 (en) | 2008-08-29 | 2011-08-24 | Transtech Pharma Inc | Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997043412A1 (en) * | 1996-05-10 | 1997-11-20 | Amgen Inc. | Novel agouti-related gene |
WO1997047316A1 (en) * | 1996-06-10 | 1997-12-18 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
-
1999
- 1999-03-30 WO PCT/US1999/006968 patent/WO1999050295A2/en active Application Filing
- 1999-03-30 AU AU39644/99A patent/AU3964499A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997043412A1 (en) * | 1996-05-10 | 1997-11-20 | Amgen Inc. | Novel agouti-related gene |
WO1997047316A1 (en) * | 1996-06-10 | 1997-12-18 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
Non-Patent Citations (2)
Title |
---|
HASKELL-LUEVANO C ET AL: "DISCOVERY OF PROTOTYPE PEPTIDOMIMETIC AGONISTS AT THE HUMAN MELANOCORTIN RECEPTORS MC1R AND MC4R", JOURNAL OF MEDICINAL CHEMISTRY, vol. 40, no. 4, 1997, pages 2133 - 2139, XP002910702, ISSN: 0022-2623 * |
YANG ET AL.: "Characterization of Agouti-related protein binding to melanocortin receptors", MOLECULAR ENDOCRINOLOGY, vol. 13, no. 1, January 1999 (1999-01-01), pages 148 - 155, XP002114621 * |
Also Published As
Publication number | Publication date |
---|---|
AU3964499A (en) | 1999-10-18 |
WO1999050295A2 (en) | 1999-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA992877B (en) | Process for the preparation of hyndrocarbons from synthesis gas. | |
IT1234978B (en) | TWO-STAGE CEMENTITIOUS MIXTURE, PARTICULARLY SUITABLE FOR ORTHOPEDIC USES. | |
WO1999050295A3 (en) | Agouti-related protein analogs and methods of use | |
AU4786585A (en) | Recovering methane enriched gas from syngas by psa. | |
WO2003006996A3 (en) | Natural ligand of gpcr chemr23 and uses thereof | |
IL131155A (en) | Assay for the measurement of dna synthesis rates | |
GB9928450D0 (en) | IGF-1 receptor interacting proteins (IIPs), genes coding therefor and uses thereof | |
WO2002097031A3 (en) | Molecules for diagnostics and therapeutics | |
EP1983059A3 (en) | Reaction mixtures for producing dipeptides | |
AU6421399A (en) | Interpretive language architecture for controlling the attributes of a physical,chemical, or thermodynamic process | |
EP1539767A4 (en) | Opiate analogs selective for the delta-opioid receptor | |
CA2165366A1 (en) | Cryogenic Rectification System for Fluorine Compound Recovery | |
DE69416359D1 (en) | Chemical cleaning through partial condensation for semiconductor production | |
WO2005116198A3 (en) | Methods of 1,3-enyne preparation using copper (i) catalysts | |
WO2003004681A3 (en) | Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon | |
IL138658A0 (en) | Chimeric protein | |
WO2002102847A1 (en) | Novel ligand and dna thereof | |
DE60105236D1 (en) | Purification method for a liquid reaction mixture from the epoxidation of 1,5,9-cyclododecatriene | |
AU2002236908A1 (en) | Systems, methods, and computer program products for determining the parameters for chemical synthesis and for supplying the reagents, equipment and/or chemicals synthesized thereby | |
WO2000005243A3 (en) | Resin derivatization method and uses thereof | |
WO2005100386A3 (en) | Canine cold-and menthol-sensitive receptor 1 | |
AU1849295A (en) | Mixing assembly for gaseous flows at different temperatures,in particular for heterogeneous exothermic synthesis reactors | |
EP1129105A4 (en) | Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey | |
WO2004003165A3 (en) | Novel polynucleotide and polypeptide sequences and uses thereof | |
WO2001062927A3 (en) | Polypeptides and corresponding polynucleotides for diagnostics and therapeutics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |